GB0309326D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0309326D0
GB0309326D0 GB0309326A GB0309326A GB0309326D0 GB 0309326 D0 GB0309326 D0 GB 0309326D0 GB 0309326 A GB0309326 A GB 0309326A GB 0309326 A GB0309326 A GB 0309326A GB 0309326 D0 GB0309326 D0 GB 0309326D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0309326A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0309326A priority Critical patent/GB0309326D0/en
Publication of GB0309326D0 publication Critical patent/GB0309326D0/en
Priority to UY27939A priority patent/UY27939A1/en
Priority to DE60317348T priority patent/DE60317348T2/en
Priority to EA200500392A priority patent/EA010130B1/en
Priority to ES03792388T priority patent/ES2295682T3/en
Priority to MXPA05001960A priority patent/MXPA05001960A/en
Priority to AT03792388T priority patent/ATE377591T1/en
Priority to AP2005003219A priority patent/AP2005003219A0/en
Priority to CA2495880A priority patent/CA2495880C/en
Priority to EA200700934A priority patent/EA012703B1/en
Priority to CNB038241293A priority patent/CN100351239C/en
Priority to TW092122692A priority patent/TW200410946A/en
Priority to PT03792388T priority patent/PT1539712E/en
Priority to DK03792388T priority patent/DK1539712T3/en
Priority to BR0313676-0A priority patent/BR0313676A/en
Priority to ARP030102997A priority patent/AR041016A1/en
Priority to OA1200500052A priority patent/OA12910A/en
Priority to US10/524,470 priority patent/US7635701B2/en
Priority to PCT/EP2003/009217 priority patent/WO2004018433A1/en
Priority to JP2004530220A priority patent/JP4583174B2/en
Priority to KR1020057002813A priority patent/KR20050058367A/en
Priority to EP03792388A priority patent/EP1539712B1/en
Priority to MYPI20033143A priority patent/MY137053A/en
Priority to UAA200501583A priority patent/UA83194C2/en
Priority to PL03376047A priority patent/PL376047A1/en
Priority to AT07119063T priority patent/ATE489369T1/en
Priority to NZ537886A priority patent/NZ537886A/en
Priority to PE2003000839A priority patent/PE20040898A1/en
Priority to EP07119063A priority patent/EP1878725B1/en
Priority to SI200331088T priority patent/SI1539712T1/en
Priority to AU2003264076A priority patent/AU2003264076B2/en
Priority to DE60335151T priority patent/DE60335151D1/en
Priority to IL16655205A priority patent/IL166552A0/en
Priority to ZA200500913A priority patent/ZA200500913B/en
Priority to EC2005005613A priority patent/ECSP055613A/en
Priority to MA28132A priority patent/MA27428A1/en
Priority to IS7749A priority patent/IS7749A/en
Priority to NO20051451A priority patent/NO20051451D0/en
Priority to HK05110876A priority patent/HK1079193A1/en
Priority to IL185549A priority patent/IL185549A0/en
Priority to CY20081100115T priority patent/CY1107871T1/en
Priority to US12/582,861 priority patent/US20100041654A1/en
Ceased legal-status Critical Current

Links

GB0309326A 2002-08-21 2003-04-24 Compounds Ceased GB0309326D0 (en)

Priority Applications (42)

Application Number Priority Date Filing Date Title
GB0309326A GB0309326D0 (en) 2003-04-24 2003-04-24 Compounds
UY27939A UY27939A1 (en) 2002-08-21 2003-08-14 COMPOUNDS
DE60335151T DE60335151D1 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators
KR1020057002813A KR20050058367A (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
UAA200501583A UA83194C2 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
ES03792388T ES2295682T3 (en) 2002-08-21 2003-08-19 DERIVATIVES OF PYRIMIDINE AND ITS USE AS MODULARS OF CB2.
MYPI20033143A MY137053A (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
AT03792388T ATE377591T1 (en) 2002-08-21 2003-08-19 PYRIMIDINE DERIVATIVES AND THEIR USE AS CB2 MODULATORS
PL03376047A PL376047A1 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
CA2495880A CA2495880C (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
EA200500392A EA010130B1 (en) 2002-08-21 2003-08-19 (tetrahydropyran-4-ylmethyl)-amide 2-(2,4-dichlorophenylamino)-4-trifluoromethylpyrimidine-5-carboxylic acid, pharmaceutical composition thereof and method for the treatment of a human or animal subject suffering from a condition which is mediated by the activity of cannabinoid 2 receptors
CNB038241293A CN100351239C (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators
TW092122692A TW200410946A (en) 2002-08-21 2003-08-19 Compounds
PT03792388T PT1539712E (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
DK03792388T DK1539712T3 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators
BR0313676-0A BR0313676A (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
ARP030102997A AR041016A1 (en) 2002-08-21 2003-08-19 PIRIMIDINE COMPOSITE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND USES ITSELF TO PREPARE SUCH COMPOSITION
OA1200500052A OA12910A (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators.
US10/524,470 US7635701B2 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators
PCT/EP2003/009217 WO2004018433A1 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
JP2004530220A JP4583174B2 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators
DE60317348T DE60317348T2 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators
EP03792388A EP1539712B1 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
MXPA05001960A MXPA05001960A (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators.
EA200700934A EA012703B1 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
AP2005003219A AP2005003219A0 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators.
AT07119063T ATE489369T1 (en) 2002-08-21 2003-08-19 PYRIMIDINE DERIVATIVES AND THEIR USE AS CB2 MODULATORS
NZ537886A NZ537886A (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators
PE2003000839A PE20040898A1 (en) 2002-08-21 2003-08-19 NEW COMPOUNDS DERIVED FROM PYRIMIDINE
EP07119063A EP1878725B1 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators
SI200331088T SI1539712T1 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as cb2 modulators
AU2003264076A AU2003264076B2 (en) 2002-08-21 2003-08-19 Pyrimidine derivatives and their use as CB2 modulators
IL16655205A IL166552A0 (en) 2002-08-21 2005-01-27 Pyrimidine derivatives and their use as cb2 modulators
ZA200500913A ZA200500913B (en) 2002-08-21 2005-02-01 Pyrimidine derivatives and their use as CB2 modulators
EC2005005613A ECSP055613A (en) 2002-08-21 2005-02-18 PIRIMIDINE DERIVATIVES AND ITS USE AS CB2 MODULATORS
MA28132A MA27428A1 (en) 2002-08-21 2005-03-07 PYRIMIDINE DERIVATIVES AND THEIR USE AS CB2 MODULATORS
IS7749A IS7749A (en) 2002-08-21 2005-03-17 Pyrimidine derivatives and their use as CB2 direct
NO20051451A NO20051451D0 (en) 2002-08-21 2005-03-18 Pyrimidine derivatives and their use as CB2 modulators
HK05110876A HK1079193A1 (en) 2002-08-21 2005-11-29 Pyrimidine derivates and their use as cb2 modulators
IL185549A IL185549A0 (en) 2002-08-21 2007-08-27 Pyrimidine derivatives and their use as cb2 modulators
CY20081100115T CY1107871T1 (en) 2002-08-21 2008-01-31 Pyrimidine derivatives and their use as CB2 regulators
US12/582,861 US20100041654A1 (en) 2002-08-21 2009-10-21 Pyrimidine Derivatives And Their Use As CB2 Modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0309326A GB0309326D0 (en) 2003-04-24 2003-04-24 Compounds

Publications (1)

Publication Number Publication Date
GB0309326D0 true GB0309326D0 (en) 2003-06-04

Family

ID=9957186

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0309326A Ceased GB0309326D0 (en) 2002-08-21 2003-04-24 Compounds

Country Status (1)

Country Link
GB (1) GB0309326D0 (en)

Similar Documents

Publication Publication Date Title
GB0309781D0 (en) Compounds
GB0316915D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
EP1689403A4 (en) Heteroaryl-hydrazone compounds
GB0304665D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0313914D0 (en) Compounds
EP1658301A4 (en) N-desmethyl-n-substituted-11-deoxyerythromycin compounds
EP1682514A4 (en) 11- o-methylgeldanamycin compounds
GB0302512D0 (en) Compounds
GB0304494D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0308105D0 (en) Compounds
GB0311688D0 (en) Compounds
GB0307998D0 (en) Compounds
GB0308017D0 (en) Compounds
GB0306595D0 (en) Compounds
GB0309326D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)